Research output: Contribution to journal › Article › peer-review
Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy. / Guelfi, Sebastian; Botia, Juan A.; Thom, Maria et al.
In: Brain : a journal of neurology, Vol. 142, No. 6, 06.2019, p. 1616-1630.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy
AU - Guelfi, Sebastian
AU - Botia, Juan A.
AU - Thom, Maria
AU - Ramasamy, Adaikalavan
AU - Perona, Marina
AU - Stanyer, Lee
AU - Martinian, Lillian
AU - Trabzuni, Daniah
AU - Smith, Colin
AU - Walker, Robert
AU - Ryten, Mina
AU - Reimers, Mark
AU - Weale, Michael E.
AU - Hardy, John
AU - Matarin, Mar
PY - 2019/6
Y1 - 2019/6
N2 - Mesial temporal lobe epilepsy with hippocampal sclerosis represents the most common epilepsy syndrome in adult patients with medically intractable partial epilepsy. Mesial temporal lobe epilepsy is usually regarded as a polygenic and complex disorder, still poorly understood but probably caused and perpetuated by dysregulation of numerous biological networks and cellular functions. The study of gene expression changes by single nucleotide polymorphisms in regulatory elements (expression quantitative trait loci, eQTLs) has been shown to be a powerful complementary approach to the detection and understanding of risk loci by genome-wide association studies. We performed a whole (gene and exon-level) transcriptome analysis on cortical tissue samples (Brodmann areas 20 and 21) from 86 patients with mesial temporal lobe epilepsy with hippocampal sclerosis and 75 neurologically healthy controls. Genome-wide genotyping data from the same individuals (patients and controls) were analysed and paired with the transcriptome data. We report potential epilepsy-risk eQTLs, some of which are specific to tissue from patients with mesial temporal lobe epilepsy with hippocampal sclerosis. We also found large transcriptional and splicing deregulation in mesial temporal lobe epilepsy with hippocampal sclerosis tissue as well as gene networks involving neuronal and glial mechanisms that provide new insights into the cause and maintenance of the seizures. These data (available via the 'Seizubraineac' web-tool resource, www.seizubraineac.org) will facilitate the identification of new therapeutic targets and biomarkers as well as genetic risk variants that could influence epilepsy and pharmacoresistance.
AB - Mesial temporal lobe epilepsy with hippocampal sclerosis represents the most common epilepsy syndrome in adult patients with medically intractable partial epilepsy. Mesial temporal lobe epilepsy is usually regarded as a polygenic and complex disorder, still poorly understood but probably caused and perpetuated by dysregulation of numerous biological networks and cellular functions. The study of gene expression changes by single nucleotide polymorphisms in regulatory elements (expression quantitative trait loci, eQTLs) has been shown to be a powerful complementary approach to the detection and understanding of risk loci by genome-wide association studies. We performed a whole (gene and exon-level) transcriptome analysis on cortical tissue samples (Brodmann areas 20 and 21) from 86 patients with mesial temporal lobe epilepsy with hippocampal sclerosis and 75 neurologically healthy controls. Genome-wide genotyping data from the same individuals (patients and controls) were analysed and paired with the transcriptome data. We report potential epilepsy-risk eQTLs, some of which are specific to tissue from patients with mesial temporal lobe epilepsy with hippocampal sclerosis. We also found large transcriptional and splicing deregulation in mesial temporal lobe epilepsy with hippocampal sclerosis tissue as well as gene networks involving neuronal and glial mechanisms that provide new insights into the cause and maintenance of the seizures. These data (available via the 'Seizubraineac' web-tool resource, www.seizubraineac.org) will facilitate the identification of new therapeutic targets and biomarkers as well as genetic risk variants that could influence epilepsy and pharmacoresistance.
KW - co-expression regulatory network
KW - hippocampal sclerosis
KW - human brain eQTLs
KW - mesial temporal epilepsy
KW - splicing
UR - http://www.scopus.com/inward/record.url?scp=85066966549&partnerID=8YFLogxK
U2 - 10.1093/brain/awz074
DO - 10.1093/brain/awz074
M3 - Article
C2 - 30932156
AN - SCOPUS:85066966549
VL - 142
SP - 1616
EP - 1630
JO - Brain
JF - Brain
SN - 0006-8950
IS - 6
ER -
King's College London - Homepage
© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454